Morningstar20 天
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously ...
In the DATROWAY arm, the interstitial lung disease (ILD ... diverse breast cancer tumor environment. With fam-trastuzumab deruxtecan-nxki, a HER2-directed ADC, AstraZeneca and Daiichi Sankyo ...